ATE470438T1 - Pharmazeutische zusammensetzung mit gasgefüllten mikrokapseln für ultraschall-vermittelte abgabe - Google Patents

Pharmazeutische zusammensetzung mit gasgefüllten mikrokapseln für ultraschall-vermittelte abgabe

Info

Publication number
ATE470438T1
ATE470438T1 AT06725707T AT06725707T ATE470438T1 AT E470438 T1 ATE470438 T1 AT E470438T1 AT 06725707 T AT06725707 T AT 06725707T AT 06725707 T AT06725707 T AT 06725707T AT E470438 T1 ATE470438 T1 AT E470438T1
Authority
AT
Austria
Prior art keywords
microcapsules
gas
mediated delivery
ultrasonic
pharmaceutical composition
Prior art date
Application number
AT06725707T
Other languages
English (en)
Inventor
Thierry Bettinger
Feng Yan
Sophie Mehier-Humbert
Peter Frinking
Original Assignee
Bracco Research Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Research Sa filed Critical Bracco Research Sa
Application granted granted Critical
Publication of ATE470438T1 publication Critical patent/ATE470438T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT06725707T 2005-04-18 2006-04-11 Pharmazeutische zusammensetzung mit gasgefüllten mikrokapseln für ultraschall-vermittelte abgabe ATE470438T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05103091A EP1714642A1 (de) 2005-04-18 2005-04-18 Pharmazeutische Formulierung mit gasgefüllten Mikrokapseln zur ultraschallgesteuerten Freisetzung
PCT/EP2006/061517 WO2006111490A1 (en) 2005-04-18 2006-04-11 Pharmaceutical composition comprising gas-filled microcapsules for ultrasound mediated delivery

Publications (1)

Publication Number Publication Date
ATE470438T1 true ATE470438T1 (de) 2010-06-15

Family

ID=34939358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06725707T ATE470438T1 (de) 2005-04-18 2006-04-11 Pharmazeutische zusammensetzung mit gasgefüllten mikrokapseln für ultraschall-vermittelte abgabe

Country Status (7)

Country Link
US (2) US20090041833A1 (de)
EP (2) EP1714642A1 (de)
JP (1) JP5049958B2 (de)
AT (1) ATE470438T1 (de)
DE (1) DE602006014819D1 (de)
ES (1) ES2346079T3 (de)
WO (1) WO2006111490A1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
WO2005027808A1 (en) 2003-09-12 2005-03-31 Z-Medica Corporation Calcium zeolite hemostatic agent
EP1667623B1 (de) 2003-09-12 2010-11-24 Z-Medica Corporation Teilweise hydriertes hämostatisches mittel
US20060178609A1 (en) 2005-02-09 2006-08-10 Z-Medica, Llc Devices and methods for the delivery of molecular sieve materials for the formation of blood clots
EP1853326B1 (de) 2005-02-15 2016-06-15 Virginia Commonwealth University Mineraltechnologien (mt) für akute hämostase und zur behandlung akuter wunden und chronischer geschwüre
US9326995B2 (en) 2005-04-04 2016-05-03 The Regents Of The University Of California Oxides for wound healing and body repair
US20090117177A1 (en) * 2005-05-23 2009-05-07 Natalia Rapoport Echogenic microbubbles and microemulsions for ultrasound-enhanced nanoparticle-mediated delivery of agents
US8938898B2 (en) 2006-04-27 2015-01-27 Z-Medica, Llc Devices for the identification of medical products
US7968114B2 (en) 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US8202532B2 (en) 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
CN101528830A (zh) 2006-07-10 2009-09-09 麦德医像公司 超弹性环氧水凝胶
US20110130444A1 (en) * 2007-05-04 2011-06-02 Stefan Moisyadi Methods and compositions for targeted delivery of gene therapeutic vectors
US20090140444A1 (en) * 2007-11-29 2009-06-04 Total Separation Solutions, Llc Compressed gas system useful for producing light weight drilling fluids
JP2011505520A (ja) 2007-12-03 2011-02-24 メディパックス インコーポレイテッド 流体計量供給装置
WO2009077921A2 (en) * 2007-12-18 2009-06-25 Koninklijke Philips Electronics, N.V. Antimicrobial filled capsules in an ultrasound field for treatment of dental biofilm
EP2090322A1 (de) 2008-02-18 2009-08-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Verwendung von FSH-Rezeptorliganden zur Diagnose und Behandlung von Krebs
JP5636363B2 (ja) * 2008-06-13 2014-12-03 ディージェイティー、 エルエルシー 衝撃波バルーンカテーテル装置
US10702293B2 (en) 2008-06-13 2020-07-07 Shockwave Medical, Inc. Two-stage method for treating calcified lesions within the wall of a blood vessel
US9072534B2 (en) 2008-06-13 2015-07-07 Shockwave Medical, Inc. Non-cavitation shockwave balloon catheter system
CA2748995C (en) 2008-10-07 2018-01-16 Bracco Suisse Sa Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same
US9180280B2 (en) * 2008-11-04 2015-11-10 Shockwave Medical, Inc. Drug delivery shockwave balloon catheter system
US9044618B2 (en) 2008-11-05 2015-06-02 Shockwave Medical, Inc. Shockwave valvuloplasty catheter system
US20100178305A1 (en) * 2008-12-15 2010-07-15 University Of Utah Research Foundation Ultrasonic nanotherapy of solid tumors with block copolymers stabilized perfluorocarbon nanodroplets
JP5667180B2 (ja) * 2009-07-01 2015-02-12 イオン メディックス インコーポレイテッド 哺乳類の有核細胞に由来するマイクロベシクル及びその用途
US9238102B2 (en) 2009-09-10 2016-01-19 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US9402812B2 (en) * 2009-09-23 2016-08-02 Indu JAVERI Methods for the preparation of liposomes
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
US20110172639A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Device and method for delivery of microneedle to desired depth within the skin
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
EP2345732A1 (de) 2010-01-19 2011-07-20 Universite Paris Descartes Verfahren zur intrazellulären Abgabe von Nukleinsäuren
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
RU2589614C2 (ru) * 2010-05-27 2016-07-10 Конинклейке Филипс Электроникс Н.В. Ультразвуковой преобразователь для избирательной генерации ультразвуковых волн и тепла
EP2603238B1 (de) * 2010-08-09 2014-07-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren und pharmazeutische zusammensetzungen zur behandlung einer augenerkrankung bei einem patienten
US8858969B2 (en) 2010-09-22 2014-10-14 Z-Medica, Llc Hemostatic compositions, devices, and methods
WO2012061556A1 (en) 2010-11-03 2012-05-10 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
JP5992920B2 (ja) * 2010-12-24 2016-09-14 ブラッコ・スイス・ソシエテ・アノニム ワクチンとしての使用のためのガス入りの微小胞
WO2012133121A1 (ja) * 2011-03-25 2012-10-04 テルモ株式会社 持続徐放性リポソーム組成物およびその製造方法
CN103930137A (zh) * 2011-10-13 2014-07-16 大学健康网络 卟啉-磷脂结合物微泡及其作为造影剂的用途
EP2847249A4 (de) 2012-03-14 2016-12-28 Medipacs Inc Intelligente polymermaterialien mit überschüssigen reaktiven molekülen
KR102189877B1 (ko) 2012-06-22 2020-12-14 지-메디카 엘엘씨 지혈 장치
US9642673B2 (en) 2012-06-27 2017-05-09 Shockwave Medical, Inc. Shock wave balloon catheter with multiple shock wave sources
ES2715678T3 (es) 2012-08-06 2019-06-05 Shockwave Medical Inc Electrodos de perfil bajo para un catéter de ondas de choque de angioplastia
CA2881211A1 (en) 2012-08-08 2014-02-13 Shockwave Medical, Inc. Shockwave valvuloplasty with multiple balloons
CN110464709A (zh) 2012-08-10 2019-11-19 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
US9138249B2 (en) 2012-08-17 2015-09-22 Shockwave Medical, Inc. Shock wave catheter system with arc preconditioning
US9333000B2 (en) 2012-09-13 2016-05-10 Shockwave Medical, Inc. Shockwave catheter system with energy control
US9522012B2 (en) 2012-09-13 2016-12-20 Shockwave Medical, Inc. Shockwave catheter system with energy control
ITFI20120184A1 (it) * 2012-09-19 2014-03-20 Raoul Cangemi Pillole curative per infezioni anaerobiche
WO2014046191A1 (ja) 2012-09-21 2014-03-27 テルモ株式会社 局所麻酔薬持続徐放性リポソーム製剤
AU2014233018A1 (en) 2013-03-15 2015-10-01 The Board Of Regents Of The University Of Texas System Liquids rich in noble gas and methods of their preparation and use
GB201320413D0 (en) * 2013-11-19 2014-01-01 Isis Innovation Cavitation-inducing polymeric nanoparticles
WO2016118947A1 (en) 2015-01-23 2016-07-28 The University Of North Carolina At Chapel Hill Apparatuses, systems, and methods for preclinical ultrasound imaging of subjects
WO2017087195A1 (en) 2015-11-18 2017-05-26 Shockwave Medical, Inc. Shock wave electrodes
US10226265B2 (en) 2016-04-25 2019-03-12 Shockwave Medical, Inc. Shock wave device with polarity switching
AU2017339980B2 (en) 2016-10-06 2022-08-18 Shockwave Medical, Inc. Aortic leaflet repair using shock wave applicators
US10357264B2 (en) 2016-12-06 2019-07-23 Shockwave Medical, Inc. Shock wave balloon catheter with insertable electrodes
US20180220681A1 (en) 2017-02-06 2018-08-09 Multi-Color Corporation High Pressure Processing Indicator
US10441300B2 (en) 2017-04-19 2019-10-15 Shockwave Medical, Inc. Drug delivery shock wave balloon catheter system
US11020135B1 (en) 2017-04-25 2021-06-01 Shockwave Medical, Inc. Shock wave device for treating vascular plaques
US10966737B2 (en) 2017-06-19 2021-04-06 Shockwave Medical, Inc. Device and method for generating forward directed shock waves
US10709462B2 (en) 2017-11-17 2020-07-14 Shockwave Medical, Inc. Low profile electrodes for a shock wave catheter
KR102245539B1 (ko) * 2018-02-12 2021-04-29 주식회사 지앤피바이오사이언스 코어-쉘 구조의 마이크로 입자를 유효성분으로 포함하는 성장인자 유전자 발현 증가용 조성물
EP3809988B1 (de) 2018-06-21 2023-06-07 Shockwave Medical, Inc. System zur behandlung von okklusionen in körperlumen
CN109679055B (zh) * 2018-12-12 2020-12-08 中国农业科学院农业质量标准与检测技术研究所 一种抗紫外改性的可降解微胶囊材料及其制备方法与应用
AU2020354380A1 (en) 2019-09-24 2022-04-07 Shockwave Medical, Inc. System for treating thrombus in body lumens
AU2021236339A1 (en) * 2020-03-12 2022-10-13 Case Western Reserve University Targeted nanobubble therapy
CN116528902A (zh) * 2020-10-13 2023-08-01 得克萨斯大学体系董事会 用于高药物/基因负载的缀合有聚合物的微泡
US11992232B2 (en) 2020-10-27 2024-05-28 Shockwave Medical, Inc. System for treating thrombus in body lumens
WO2022260678A1 (en) * 2021-06-11 2022-12-15 Dnalite Therapeutics, Inc. Compositions and methods for biological delivery vehicles
US12023098B2 (en) 2021-10-05 2024-07-02 Shockwave Medical, Inc. Lesion crossing shock wave catheter
CN114259606A (zh) * 2022-01-27 2022-04-01 珠海市立通生物科技有限公司 一种药物球囊导管及药物球囊的表面处理方法
US12035932B1 (en) 2023-04-21 2024-07-16 Shockwave Medical, Inc. Intravascular lithotripsy catheter with slotted emitter bands

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB486442A (en) 1936-12-02 1938-06-02 Martin Constan Schwab Improvements in apparatus for dispensing liquids for surgical injection and other purposes
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
AU2698684A (en) 1983-07-01 1985-02-07 Battelle Memorial Institute Polypeptide biodegradable et son utilisation pour le relargage progressif de medicaments
JPS60141837A (ja) 1983-12-28 1985-07-26 Mitsui Mining & Smelting Co Ltd マンガンノジユ−ルの湿式処理法
US4543101A (en) * 1984-03-28 1985-09-24 Adria Laboratories, Inc. Valve device to aid in reconstituting injectable powders
ATE60340T1 (de) * 1984-10-19 1991-02-15 Battelle Memorial Institute Durch mikroorganismen abbaubares polypeptid und seine verwendung fuer die fortschreitende abgabe von medikamenten.
CH667874A5 (fr) 1985-12-19 1988-11-15 Battelle Memorial Institute Polypeptide synthetique biodegradable et son utilisation pour la preparation de medicaments.
US4722733A (en) 1986-02-26 1988-02-02 Intelligent Medicine, Inc. Drug handling apparatus and method
IE61591B1 (en) 1987-12-29 1994-11-16 Molecular Biosystems Inc Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
IN172208B (de) * 1990-04-02 1993-05-01 Sint Sa
US5556610A (en) * 1992-01-24 1996-09-17 Bracco Research S.A. Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
IL104084A (en) 1992-01-24 1996-09-12 Bracco Int Bv Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
WO1995007072A2 (de) * 1993-09-09 1995-03-16 Schering Aktiengesellschaft Wirkstoffe und gas enthaltende mikropartikel
US6333021B1 (en) * 1994-11-22 2001-12-25 Bracco Research S.A. Microcapsules, method of making and their use
IL116328A (en) * 1994-12-16 1999-09-22 Bracco Research Sa Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging
US5830430A (en) * 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
IL114960A0 (en) 1995-03-20 1995-12-08 Medimop Medical Projects Ltd Flow control device
US6521211B1 (en) * 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6139819A (en) * 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
EP0973552B1 (de) 1996-10-28 2006-03-01 Amersham Health AS Verbesserungen an oder in verbindung mit diagnotischen/therapeutischen verbindungen
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6045777A (en) * 1997-06-30 2000-04-04 Acusphere, Inc. Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases
US6896659B2 (en) * 1998-02-06 2005-05-24 Point Biomedical Corporation Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
AU2660199A (en) * 1998-02-06 1999-08-23 Point Biomedical Corporation Method for ultrasound triggered drug delivery
GB9809084D0 (en) 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
AU6636000A (en) * 1999-08-13 2001-03-13 Point Biomedical Corporation Hollow microspheres with controlled fragility for medical use
WO2002005544A1 (fr) 2000-07-06 2002-01-17 Seiko Epson Corporation Procede de traitement d'image, support d'enregistrement, et dispositif de traitement d'image
CA2432474C (en) 2000-12-23 2012-06-26 Dyax Corp. Fibrin binding polypeptides useful inter alia in medical imaging processes
JP4945040B2 (ja) * 2001-09-28 2012-06-06 株式会社東芝 超音波診断装置
JP2005519980A (ja) 2002-03-01 2005-07-07 ブラッコ インターナショナル ビー．ヴイ． 治療および診断用途の多価構成物
EP2301587B1 (de) 2002-03-01 2014-06-25 Dyax Corp. KDR- und VEGF/KDR-bindende Peptide sowie ihre Verwendung bei der Diagnose und Therapie
CN1732023A (zh) * 2002-12-27 2006-02-08 血管技术国际股份公司 组合物和使用collajolie的方法
DE602004029010D1 (de) 2003-02-04 2010-10-21 Bracco Suisse Sa Ultraschall kontrastmittel und verfahren zur erstellung
US20040258760A1 (en) * 2003-03-20 2004-12-23 Wheatley Margaret A. Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production

Also Published As

Publication number Publication date
EP1714642A1 (de) 2006-10-25
US20090041833A1 (en) 2009-02-12
US20110208115A1 (en) 2011-08-25
EP1879558B1 (de) 2010-06-09
WO2006111490A1 (en) 2006-10-26
DE602006014819D1 (de) 2010-07-22
JP5049958B2 (ja) 2012-10-17
JP2008538367A (ja) 2008-10-23
ES2346079T3 (es) 2010-10-08
EP1879558A1 (de) 2008-01-23
US9375397B2 (en) 2016-06-28

Similar Documents

Publication Publication Date Title
ATE470438T1 (de) Pharmazeutische zusammensetzung mit gasgefüllten mikrokapseln für ultraschall-vermittelte abgabe
GB2340040B (en) Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
ATE494885T1 (de) Feste arzneimittelformulierung und vorrichtung zu ihrer aufbewahrung und kontrollierten abgabe
PT1183014E (pt) Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
IL173078A0 (en) Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
ATE510514T1 (de) Dentalfüllmaterial
BRPI0810390A2 (pt) Película, composição, e, métodos para administrar um material ativo, para melhorar a estabilidade de uma película e para manter a saúde sistêmica de um mamífero
TW200640498A (en) Suspending vehicles and pharmaceutical suspensions for drug dosage forms
EA200701655A1 (ru) Материалы для доставки лекарств, полученные золь-гелевым методом
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
EP1594477A4 (de) Wirkstoffabgabe im gastrointestinaltrakt
WO2005097064A3 (en) Taste-masked drugs in rupturing multiparticulates
MX2007009075A (es) Protesis y metodo para fabricar una protesis.
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
WO2005065642A3 (en) Drug delivery device
JP2009502405A5 (de)
DK1895994T3 (da) Multilagsmedikamentleveringssystem med barriere mod reservoirmaterialeflow
BG109430A (en) FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION
WO2004098537A3 (en) Activation agents on the surface of encapsulation vesicles
EP1882483A3 (de) Material zum Tragen eines medizinischen Implantats
PE20070077A1 (es) Comprimido con recubierta con azucar
HK1112575A1 (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
WO2006007351A3 (en) Squeeze controlled oral dosage form
DE602004023093D1 (de) N mit einem abgabemittel in mikronisierter form
DE602006003073D1 (de) Neue weichgelatinekapseln

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties